Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 195

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 195
---
 in whose favor judgment was given or on the part of the court; |

| ● | recognition or enforcement of the judgment in the British Virgin Islands would not be contrary to public policy; and |
| ● | the proceedings pursuant to which judgment was obtained were not contrary to natural justice.                        |

In appropriate circumstances,
a British Virgin Islands Court may give effect in the British Virgin Islands to other kinds of final foreign judgments such as declaratory
orders, orders for performance of contracts and injunctions.

<div align='center'>115

WHERE YOU CAN FIND ADDITIONAL INFORMATION</div>

We have filed with the SEC
a registration statement on Form F-1 under the Securities Act relating to this registration of the Ordinary Shares to be offered in this
Best Efforts Offering. This prospectus, which is part of the Registration Statement, does not contain all of the information contained
in the Registration Statement. The rules and regulations of the SEC allow us to omit certain information from this prospectus that is
included in the Registration Statement. Statements made in this prospectus concerning the contents of any contract, agreement or other
document are summaries of all material information about the documents summarized, but are not complete descriptions of all terms of these
documents. If we filed any of these documents as an exhibit to the Registration Statement, you may read the document itself for a complete
description of its terms.

We are subject to the periodic
reporting and other information requirements of the Exchange Act as applicable to a “Foreign Private Issuer,” and we will
file annual reports and other information from time to time with the SEC in accordance with such requirements. Our filings with the SEC
are also available to the public through the SEC’s website at www.sec.gov.

As a foreign private issuer,
we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and
our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained
in Section 16 of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic reports and financial
statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.

We maintain a corporate website
at www.newgenivf.com. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus.
We have included our website address in this prospectus solely as an inactive textual reference. We will post